@article {Franklin:1998:1532-0820:334,
title = "Enterohepatic Lesions in SCID Mice Infected with Helicobacter bilis",
journal = "Comparative Medicine",
parent_itemid = "infobike://aalas/cm",
publishercode ="aalas",
year = "1998",
volume = "48",
number = "4",
publication date ="1998-08-01T00:00:00",
pages = "334-339",
itemtype = "ARTICLE",
issn = "1532-0820",
eissn = "2769-819X",
url = "https://www.ingentaconnect.com/content/aalas/cm/1998/00000048/00000004/art00006",
author = "Franklin, Craig L. and Riley, Lela K. and Livingston, Robert S. and Beckwith, Catherine S. and Besch-Williford, Cynthia L. and Hook, Jr., Reuel R.",
abstract = " Helicobacter bilis is a recently identified species that colonizes the intestine and liver of mice. In immunocompetent mice, infections have been associated with mild hepatitis, and in immunocompromised mice, inflammatory bowel disease has been induced by intraperitoneal inoculation of the organism. We report inoculation of 6-week-old C. B-17 scid/scid mice by gastric gavage with approximately 107 H. bilis colony-forming units. Groups of mice were euthanized and necropsied 12, 24, and 36 weeks after inoculation. Mild to moderate proliferative typhlitis was evident in all mice at 12 and 36 weeks after inoculation and in most mice 24 weeks after inoculation. Mild to severe chronic active hepatitis was detected in 10 of 10 male mice and 3 of 10 female mice. These results indicate that H. bilis can cause moderate to severe enterohepatic disease in immunocompromised mice.",
}